Comparison of conventional and 3-dimensional computed tomography against histopathologic examination in determining pancreatic adenocarcinoma tumor size: Implications for radiation therapy planning

Radiotherapy and Oncology

Volumn 104, Issue 2, 2012, Pages 167-172

  Qiu, Haoming ^a   Wild, Aaron T ^a   Wang, Hao ^b   Fishman, Elliot K ^b   Hruban, Ralph H ^b   Laheru, Daniel A ^b   Kumar, Rachit ^a   Hacker Prietz, Amy ^a   Tuli, Richard ^a   Tryggestad, Erik ^a   Schulick, Richard D ^b   Cameron, John L ^b   Edil, Barish H ^b   Pawlik, Timothy M ^b   Wolfgang, Christopher L ^b   Herman, Joseph M ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

3D CT; Pancreatic cancer; Radiation treatment planning; Resectable; SBRT

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SIZE; COMPARATIVE EFFECTIVENESS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CONVENTIONAL COMPUTED TOMOGRAPHY; DOSIMETRY; FEMALE; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PANCREAS ADENOCARCINOMA; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THREE DIMENSIONAL COMPUTER ASSISTED TOMOGRAPHY; TREATMENT PLANNING;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMAGING, THREE-DIMENSIONAL; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PANCREATECTOMY; PANCREATIC NEOPLASMS; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84865720829     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2012.07.004     Document Type: Article

References (21)

1. F. Huguet, N. Girard, C.S. Guerche, C. Hennequin, F. Mornex, and D. Azria Chemoradiotherapy in the management of locally advanced pancreatic carcinoma: a qualitative systematic review J Clin Oncol 1 2009 2269 2277
2. K.A. Goodman, W.F. Regine, L.A. Dawson, E. Ben-Josef, K. Haustermans, and W.R. Bosch Radiation therapy oncology group consensus panel guidelines for the delineation of the clinical target volume in the postoperative treatment of pancreatic head cancer Int J Radiat Oncol Biol Phys 83 2012 901 908
3. G. Whitfield, P. Jain, M. Green, G. Watkins, A. Henry, and J. Stratford Quantifying motion for pancreatic radiotherapy margin calculation Radiother Oncol 103 2012 360 366
4. F. Polistina, G. Costantin, F. Casamassima, P. Francescon, R. Guglielmi, and G. Panizzoni Unresectable locally advanced pancreatic cancer: a multimodal treatment using neoadjuvant chemoradiotherapy (gemcitabine plus stereotactic radiosurgery) and subsequent surgical exploration Ann Surg Oncol 17 2010 2092 2101
5. C.P. Li, Y. Chao, and K.H. Chi Concurrent chemoradiotherapy treatment of locally advanced pancreatic cancer: Gemcitabine versus 5-fluorouracil, a randomized controlled study Int J Radiat Oncol Biol Phys 57 2003 98 104
6. J.D. Murphy, S. Adusumilli, and K.A. Griffith Full-dose gemcitabine and concurrent radiotherapy for unresectable pancreatic cancer Int J Radiat Oncol Biol Phys 68 2007 801
7. M. Hoyer, H. Roed, L. Sengelov, A. Traberg, L. Ohlhuis, and J. Pedersen Phase-II study on stereotactic radiotherapy of locally advanced pancreatic carcinoma Radiother Oncol 76 2005 48 53
8. D.T. Chang, D. Schellenberg, and J. Shen Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreas Cancer 115 2009 665 672
9. J.D. Murphy, C. Christman-Skieller, and J. Kim A dosimetric model of duodenal toxicity after stereotactic body radiotherapy for pancreatic cancer Int J Radiat Oncol Biol Phys 78 2010 1420 1426
10. N.D. Arvold, A. Niemierko, and J.H. MAmon Pancreatic cancer tumor size on CT scan versus pathologic specimen: implications for radiation treatment planning Int J Radiat Oncol Biol Phys 80 2011 1383 1390
11. E.K. Fishman, K.M. Horton, and B.A. Urban Multidetector CT angiography in the evaluation of pancreatic carcinoma: preliminary observations J Comput Assist Tomogr 24 2000 849 853
12. Westra WH, Hruban, RH, Phelps TH, et al. In: Surgical pathology: an illustrated guide. 2nd ed. New York, NY: Springer; 2002.
13. J.L. Humphris, D.K. Chang, A.L. Johns, C.J. Scarlett, M. Pajic, and M.D. Jones The prognostic and predictive value of serum CA19.9 in pancreatic cancer Ann Oncol 2012
14. H. Akaike Factor analysis and AIC Psychometrika 52 1987 317 332
15. T.M. Pawlik, D. Laheru, R.H. Hruban, J. Coleman, C.L. Wolfgang, and K. Campbell Evaluating the impact of a single-day multidisciplinary clinic on the management of pancreatic cancer Ann Surg Oncol 15 2008 2081 2088
16. M.G. House, C.J. Yeo, and J.L. Cameron Predicting resectability of periampullary cancer with three-dimensional computed tomography J Gastrointest Surg 8 2004 280 288
17. H. Furukawa, K. Takayasu, and K. Mukai Computed tomography of pancreatic adenocarcinoma: comparison of tumor size measured by dynamic computed tomography and histopathologic examination Pancreas 13 1996 231 235
18. Y.C. Kim, H.J. Kim, and J.H. Park Can preoperative CA19-9 and CEA levels predict the resectability of patients with pancreatic adenocarcinoma? J Gastroenterol Hepatol 24 2009 1869 1875
19. K.P. Croome, S. Jayaraman, and C.M. Schlachta Preoperative staging of cancer of the pancreatic head: is there room for improvement? Can J Surg 53 2010 171 174
20. K. Aoki, S. Okada, and N. Moriyama Accuracy of computed tomography in determining pancreatic cancer tumor size Jpn J Clin Oncol 24 1994 85 87
21. G. Klöppel, R.H. Hruban, and D.S. Longnecker Ductal adenocarcinoma of the pancreas. Tumors of the exocrine pancreas S.R. Hamilton, L.A. Aaltonen, Pathology and Genetics of Tumours of the Digestive System, World Health Organization Classification of Tumours 2000 IARC Press Lyon, France 221 230